Lanean...
ADVANCING THE MRD CONCEPT IN ACUTE MYELOID LEUKEMIA
The criteria to evaluate response to treatment in acute myeloid leukemia (AML) have changed little in the past sixty years. It is now possible to use higher sensitivity tools to measure residual disease burden in AML. Such minimal or measurable residual disease (MRD) measurements provide a deeper un...
Gorde:
| Argitaratua izan da: | Semin Hematol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4484880/ https://ncbi.nlm.nih.gov/pubmed/26111465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2015.04.001 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|